CMMB — Chemomab Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-American Airlines, Oatly Group, Abbvie
U.S. STOCKS ON THE MOVE-YEXT Inc, Stitch Fix, Match Group
Chemomab Therapeutics surges after changes to clinical programs
Chemomab Therapeutics Ltd reports results for the quarter ended in December - Earnings Summary
Brief: Chemomab Therapeutics Announces Fourth Quarter And Year End 2021 Financial Results And Provides A Corporate Update
Chemomab Therapeutics Ltd expected to post a loss of 10 cents a share - Earnings Preview
Brief: Chemomab Therapeutics Names Jack Lawler Vice President Of Global Clinical Development Operations
Brief: Chemomab Therapeutics Announces Expected Appointment Of Dale R. Pfost As Chairman
U.S. STOCKS ON THE MOVE-DocuSign, Esperion, Longeveron, Didi
Brief: Chemomab Therapeutics Names David M. Weiner, MD As Interim Chief Medical Officer
U.S. STOCKS ON THE MOVE-Apple, CF Acquisition, Tantech, MEI Pharma
U.S. STOCKS ON THE MOVE-Omeros, CF Acquisition, Chemomab, Phunware
Brief: Chemomab Announces FDA Clearance Of IND Application For CM-101
Chemomab jumps as FDA accepts application for rare disease therapy trial
Brief: Chemomab Therapeutics Announces Third Quarter 2021 Financial Results
Brief: Chemomab Therapeutics Announces Collaboration With Leeds University To Further Elucidate Role Of CCL24 In Vascular Damage Associated With Systemic Sclerosis
Brief: Chemomab Therapeutics Announces Appointment Of Dale Pfost As Chief Executive Officer
Brief: Chemomab Therapeutics And AGC Biologics Expand Partnership
Brief: Chemomab Therapeutics And AGC Biologics Expand Partnership